Sanara MedTech (SMTI) Competitors $29.76 -0.20 (-0.67%) As of 02:45 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SMTI vs. MDXG, TNDM, INMD, IRMD, BBNX, EMBC, AXGN, CLPT, SIBN, and BFLYShould you be buying Sanara MedTech stock or one of its competitors? The main competitors of Sanara MedTech include MiMedx Group (MDXG), Tandem Diabetes Care (TNDM), InMode (INMD), iRadimed (IRMD), Beta Bionics (BBNX), Embecta (EMBC), AxoGen (AXGN), ClearPoint Neuro (CLPT), SiBone (SIBN), and Butterfly Network (BFLY). These companies are all part of the "medical equipment" industry. Sanara MedTech vs. Its Competitors MiMedx Group Tandem Diabetes Care InMode iRadimed Beta Bionics Embecta AxoGen ClearPoint Neuro SiBone Butterfly Network Sanara MedTech (NASDAQ:SMTI) and MiMedx Group (NASDAQ:MDXG) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, earnings, profitability, risk and dividends. Does the media favor SMTI or MDXG? In the previous week, MiMedx Group had 2 more articles in the media than Sanara MedTech. MarketBeat recorded 5 mentions for MiMedx Group and 3 mentions for Sanara MedTech. MiMedx Group's average media sentiment score of 0.83 beat Sanara MedTech's score of 0.83 indicating that MiMedx Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sanara MedTech 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive MiMedx Group 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders have more ownership in SMTI or MDXG? 8.1% of Sanara MedTech shares are owned by institutional investors. Comparatively, 79.2% of MiMedx Group shares are owned by institutional investors. 42.6% of Sanara MedTech shares are owned by insiders. Comparatively, 1.7% of MiMedx Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has more risk & volatility, SMTI or MDXG? Sanara MedTech has a beta of 1.21, indicating that its share price is 21% more volatile than the S&P 500. Comparatively, MiMedx Group has a beta of 1.73, indicating that its share price is 73% more volatile than the S&P 500. Do analysts recommend SMTI or MDXG? Sanara MedTech currently has a consensus price target of $50.00, indicating a potential upside of 68.01%. MiMedx Group has a consensus price target of $12.00, indicating a potential upside of 79.78%. Given MiMedx Group's stronger consensus rating and higher probable upside, analysts plainly believe MiMedx Group is more favorable than Sanara MedTech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sanara MedTech 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33MiMedx Group 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Is SMTI or MDXG more profitable? MiMedx Group has a net margin of 8.84% compared to Sanara MedTech's net margin of -10.22%. MiMedx Group's return on equity of 23.03% beat Sanara MedTech's return on equity.Company Net Margins Return on Equity Return on Assets Sanara MedTech-10.22% -26.43% -10.69% MiMedx Group 8.84%23.03%17.09% Which has stronger earnings & valuation, SMTI or MDXG? MiMedx Group has higher revenue and earnings than Sanara MedTech. Sanara MedTech is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSanara MedTech$86.67M3.06-$9.66M-$1.16-25.66MiMedx Group$348.88M2.83$42.42M$0.2131.79 SummaryMiMedx Group beats Sanara MedTech on 13 of the 16 factors compared between the two stocks. Get Sanara MedTech News Delivered to You Automatically Sign up to receive the latest news and ratings for SMTI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SMTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMTI vs. The Competition Export to ExcelMetricSanara MedTechMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$264.86M$10.30B$6.03B$10.49BDividend YieldN/A1.89%5.73%4.80%P/E Ratio-25.6620.4384.8927.32Price / Sales3.0632.26516.27196.49Price / CashN/A25.0637.5761.53Price / Book6.693.4612.396.78Net Income-$9.66M$208.83M$3.32B$276.59M7 Day Performance-7.95%-0.43%0.22%-0.21%1 Month Performance-15.00%3.62%9.87%7.65%1 Year Performance-7.41%-4.01%75.52%33.95% Sanara MedTech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMTISanara MedTech2.5969 of 5 stars$29.76-0.7%$50.00+68.0%-6.0%$264.86M$86.67M-25.6660MDXGMiMedx Group3.545 of 5 stars$7.33+0.3%$12.00+63.6%+14.8%$1.08B$348.88M34.84870News CoverageTNDMTandem Diabetes Care4.2209 of 5 stars$14.90-0.7%$22.44+50.6%-61.5%$1.00B$940.20M-4.802,650Analyst ForecastINMDInMode2.6253 of 5 stars$15.17-0.4%$18.04+18.9%-7.3%$959.15M$394.82M6.14480Positive NewsIRMDiRadimed4.5732 of 5 stars$74.89+4.4%$72.00-3.9%+45.4%$952.23M$77.64M46.23110News CoverageInsider TradeBBNXBeta Bionics2.1099 of 5 stars$21.81-0.6%$24.44+12.1%N/A$948.08M$65.12M0.00294EMBCEmbecta4.6013 of 5 stars$13.97-1.5%$19.00+36.0%+3.4%$817.63M$1.12B9.782,100AXGNAxoGen3.0497 of 5 stars$16.98-1.1%$25.75+51.7%+11.4%$780.79M$187.34M-169.68450CLPTClearPoint Neuro0.8315 of 5 stars$25.26-5.0%$19.67-22.1%+109.8%$719.90M$31.39M-31.26110Insider TradeSIBNSiBone3.9689 of 5 stars$14.53+0.3%$23.67+62.9%+16.5%$626.84M$185.26M-25.95350Analyst ForecastBFLYButterfly Network3.0068 of 5 stars$2.42-5.7%$3.00+24.2%+32.7%$605.44M$82.06M-8.59460Gap Up Related Companies and Tools Related Companies MiMedx Group Competitors Tandem Diabetes Care Competitors InMode Competitors iRadimed Competitors Beta Bionics Competitors Embecta Competitors AxoGen Competitors ClearPoint Neuro Competitors SiBone Competitors Butterfly Network Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SMTI) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanara MedTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanara MedTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
